Flagellate Erythema Secondary to Bleomycin for Non-Seminomatous Testis Tumor
Article Sidebar
Main Article Content
Abstract
The development of flagellate erythema secondary to bleomycin treatment is a rare adverse effect. The prevalence varies between 8 to 22% of patients and it is becoming rarer. Flagellate erythema presents as a scaly erythematous papule. A lower amount of bleomycin hydrolase in regions with reduced production, such as skin and lungs, decreases bleomycin degradation, which allows its accumulation in tissues, triggering an inflammatory process, especially in patients with lower basal enzyme function. We report a clinical case of a severe presentation of flagellate erythema secondary to a patient ongoing bleomycin, etoposide and platinum (BEP) based chemotherapy of non-seminomatous testis cancer.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
McEvoy GK, American Society of Health-System Pharmacists. AHFS Drug information 2008. Bethesda, Md.: American Society of Health-System Pharmacists; 2008.
Gilman AG, Goodman LS, Nies AS, organizadores. Goodman and Gilman’s the pharmacological basis of therapeutics. 8. ed. New York: McGraw-Hill; 1993. 1811 p.
Yamamoto T. Bleomycin and the skin. Br J Dermatol. novembro de 2006;155(5):869–75.
Ziemer M, Goetze S, Juhasz K, Elsner P. Flagellate Dermatitis as a Bleomycin-Specific Adverse Effect of Cytostatic Therapy: A Clinical-Histopathologic Correlation. Am J Clin Dermatol. fevereiro de 2011;12(1):68–76.
Chen Y-B, Rahemtullah A, Breeden E, Hochberg EP. Bleomycin-Induced Flagellate Erythema. J Clin Oncol. 1o de março de 2007;25(7):898–900.
Fyfe A, McKay P. Toxicities associated with bleomycin. J R Coll Physicians Edinb. 13 de setembro de 2010;40(3):213–5.
Al-Khenaizan S, Al-Berouti B. Flagellate pigmentation: a unique adverse effect of bleomycin therapy. Eur J Dermatol EJD. fevereiro de 2011;21(1):146.
Polla L, Mérot Y, Slosman D, Polla B, Olgiati D, Saurat JH. [Linear pigmentogenic dermitis after scintigraphy using bleomycin]. Ann Dermatol Venereol. 1985;112(10):821–3.